Fatty liver disease is now one of the most common liver conditions in the world, affecting nearly one in three adults. It happens when too much fat builds up inside the liver, an organ that plays a key role in filtering toxins, storing energy, and helping digestion.
In many people, fatty liver disease is linked to obesity, diabetes, or poor diet. In others, alcohol use is a major cause.
Doctors often struggle to tell which factor is driving the disease, especially when patients are unsure about their drinking habits or feel uncomfortable discussing them. This uncertainty can delay the right treatment and allow liver damage to worsen over time.
Researchers at the University of California San Diego School of Medicine have developed a new tool that may solve this problem.
The study, published in the journal Gastroenterology, describes a simple blood test score that helps doctors identify whether fatty liver disease is likely caused by alcohol rather than metabolic factors such as weight or blood sugar. The tool is called the MetALD-ALD Prediction Index, or MAPI.
MAPI uses five routine laboratory values that are already collected during standard medical visits. Because these tests are commonly performed, the score can be calculated without extra procedures, cost, or equipment.
By analyzing these results together, the score estimates whether alcohol-related injury is contributing to liver damage, even when alcohol use is not clearly reported. This makes it especially useful because alcohol intake is often underestimated in medical records.
In the study, scientists analyzed data from more than 500 adults in the San Diego area and about 1,800 people in Sweden. They found that the MAPI score performed better than many existing blood tests at identifying alcohol-related liver injury.
The tool also helped doctors decide when a more specialized alcohol test, called phosphatidylethanol or PEth, might be necessary. Although PEth testing is very accurate, it can be expensive or unavailable in some clinics. Using MAPI as a first step could make screening more accessible and efficient.
Fatty liver disease can progress silently for years without obvious symptoms. If alcohol is a major factor and remains unrecognized, the condition may advance to inflammation, scarring, or even liver failure.
Early detection allows doctors to recommend lifestyle changes, counseling, and treatment strategies tailored to the patient’s situation. Identifying alcohol-related damage also helps prevent complications and reduces the risk of hospitalization or death.
The researchers believe the tool could be especially helpful in primary care settings, where most cases of fatty liver disease are first discovered during routine checkups.
It may also improve communication between doctors and patients by providing clear, objective information about possible causes of liver injury. This transparency could reduce stigma and encourage honest conversations about alcohol use, leading to better long-term outcomes.
While the results are promising, the study also has limitations. It focused on specific populations, and further research is needed to confirm that the tool works equally well in different ethnic groups and health systems. Scientists also plan to test MAPI in larger studies and clinical trials to see how it performs in everyday medical practice.
Overall, the findings suggest that a simple combination of routine blood tests may provide valuable insight into the causes of fatty liver disease. The study highlights how better classification of liver conditions can lead to more personalized care and earlier intervention.
However, the score should be used as part of a comprehensive evaluation rather than as the only basis for diagnosis. Doctors still need to consider medical history, lifestyle factors, and other tests when making decisions.
This research represents an important step toward improving liver disease detection and management.
By helping doctors recognize hidden alcohol-related injury sooner, the new tool could prevent severe complications and support healthier aging for millions of people worldwide. If validated in future studies, MAPI may become a practical addition to routine care, offering a clearer path to protecting liver health.
If you care about liver health, please read studies about simple habit that could give you a healthy liver, and common diabetes drug that may reverse liver inflammation.
For more information about health, please see recent studies about simple blood test that could detect your risk of fatty liver disease, and results showing this green diet may strongly lower non-alcoholic fatty liver disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
